Erfahrungsbericht über das Medusa-Pessar MPL-Cu-240-Ag [PDF]
, 1984 Byron Ellsworth Hamann +2 more
openalex +1 more source
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach
Allergy, EarlyView.The MCID for CSMS0–6 was derived via a questionnaire (N = 1071) and by applying a justified threshold for the validated RQLQ(S) score as an anchor to RESONATE Phase III (G306) data. The outcome of a Phase III AIT is positive when statistical significance is achieved in combination with a difference of at least −0.22 points (CSMS0–6) and/or −16 ...
Oliver Pfaar +17 more
wiley +1 more source
Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity [PDF]
, 1994 Laurence Bénit +5 more
openalex +1 more source
When, which and how to switch: Navigating JAK inhibitors in myelofibrosis
British Journal of Haematology, EarlyView.Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi‐naïve and for those who have previously been treated with a JAKi.
Jennifer O'Sullivan +2 more
wiley +1 more source
Case Study - IPv6 based building automation solution integration into an IPv4 Network Service Provider infrastructure [PDF]
, 2012 The case study presents a case study describing an Internet Protocol (IP) version 6 (v6) introduction to an IPv4 Internet Service Provider (ISP) network infrastructure.
Bogomilov, Ivan, Milovanov, Nikolay
core
Guangtongxin yanjiu, 2007 目前的发展趋势表明,T-MPLS（传送多协议标签交换）将逐渐成为一种新的传送机制。文章介绍了端到端PW（伪线）模型,分析了T-MPLS网络的信号封装机制,提出了基于PW的T-MPLS层网络与以太网互通模型。在此基础上文章结合T-MPLS信号封装机制,详细讨论了基于PW的以太网互通模型。
樊自甫, 万晓榆
doaj
Activating Mutations of the Transmembrane Domain of MPL In Vitro and In Vivo: Incorrect Sequence of MPL-K, an Alternative Spliced Form of MPL [PDF]
, 1998 Toshio Kitamura +4 more
openalex +1 more source
Primary myelofibrosis with increased haemoglobin concentration at presentation
British Journal of Haematology, EarlyView.Subjects with primary myelofibrosis and elevated haemoglobin levels at diagnosis tend to have longer survival rates (OS) and blast transformation‐free survival (BTFS) than those with normal or reduced haemoglobin levels. Summary One hundred of 963 consecutive registrants with primary myelofibrosis (PMF) in the Pavia‐CSM database had haemoglobin ...
Giovanni Barosi +8 more
wiley +1 more source
Cytokine Production and Function in c-mpl–Deficient Mice: No Physiologic Role for Interleukin-3 in Residual Megakaryocyte and Platelet Production [PDF]
, 1998 Timothy Gainsford +8 more
openalex +1 more source
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study
European Journal of Haematology, EarlyView.ABSTRACT Momelotinib, a novel JAK1/2 inhibitor with inhibitory activities on activin A receptor type I, has shown breakthrough clinical efficacy in patients with myelofibrosis (MF) and anemia, a disease‐related manifestation of challenging management. In this retrospective real‐life multicenter Italian study, we investigated the safety and efficacy of ...
Maria Carmen Martorelli +34 more
wiley +1 more source